Alnylam Pharmaceuticals owns U.S. Patent Nos. 11,246,933 (parent) and 11,382,979 (child). These patents relate to biodegradable lipids and their use for the delivery of active agents such as nucleic ...

The problem of definition has a long history and has engaged the minds of some of the most eminent thinkers in the Western tradition, from Plato and Aristotle onwards. But it is also an everyday ...

Summary: Once the high threshold for lexicography is met, there must be a clear and unmistakable reason to depart from that controlling definition. Alnylam sued Moderna, alleging that Moderna’s ...